MX9805499A - Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. - Google Patents

Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Info

Publication number
MX9805499A
MX9805499A MX9805499A MX9805499A MX9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A MX 9805499 A MX9805499 A MX 9805499A
Authority
MX
Mexico
Prior art keywords
diazacycloheptane
compounds
cyclooctane
substituted aza
aza
Prior art date
Application number
MX9805499A
Other languages
English (en)
Inventor
Hans-Joerg Treiber
Stefan Blank
Dorothea Starck
Liliane Unger
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of MX9805499A publication Critical patent/MX9805499A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)

Abstract

La presente invencion se refiere a compuestos de azacicloheptano y diazacicloheptano y ciclooctano de la siguiente formula (I) Ar1-A-B-Ar2 donde Ar1; A; B y Ar2 tienen los significados proporcionados en la descripcion. Los compuestos de conformidad con la presente invencion poseen una alta afinidad con los receptores de dopamina D3 y pueden por consiguiente emplearse para el tratamiento de enfermedades que reaccionan con ligandos de dopamina D3.
MX9805499A 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso. MX9805499A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19600934A DE19600934A1 (de) 1996-01-12 1996-01-12 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung

Publications (1)

Publication Number Publication Date
MX9805499A true MX9805499A (es) 1998-11-30

Family

ID=7782613

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805499A MX9805499A (es) 1996-01-12 1998-07-07 Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.

Country Status (26)

Country Link
US (2) US6214822B1 (es)
EP (1) EP0877744B1 (es)
JP (1) JP4349657B2 (es)
KR (1) KR100441073B1 (es)
CN (2) CN1075070C (es)
AR (1) AR005868A1 (es)
AT (1) ATE273301T1 (es)
AU (1) AU717726B2 (es)
BG (1) BG64098B1 (es)
CA (1) CA2241787C (es)
CO (1) CO4790173A1 (es)
CZ (1) CZ297981B6 (es)
DE (2) DE19600934A1 (es)
ES (1) ES2225947T3 (es)
HR (1) HRP970021A2 (es)
HU (1) HU228457B1 (es)
IL (1) IL125076A (es)
MX (1) MX9805499A (es)
NO (1) NO316753B1 (es)
NZ (1) NZ326332A (es)
PL (1) PL327692A1 (es)
SK (1) SK284987B6 (es)
TR (1) TR199801302T2 (es)
TW (1) TW475929B (es)
WO (1) WO1997025324A1 (es)
ZA (1) ZA97209B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
DE69929704T2 (de) 1998-10-08 2006-07-20 Smithkline Beecham Plc, Brentford Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
AR022230A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
DE19922443A1 (de) 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists
WO2001072306A1 (de) * 2000-03-27 2001-10-04 Basf Aktiengesellschaft Verwendung von dopamin-d3-rezeptor-liganden zur behandlung von erkrankungen des zentralen nervensystems
CA2438264A1 (en) 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10131543A1 (de) * 2001-06-29 2003-01-16 Abbott Lab Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung
WO2003045926A1 (fr) * 2001-11-28 2003-06-05 Societe De Conseils De Recherche Et D'applications Scientifiques (S.C.R.A.S.) Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicament
CN1642422A (zh) * 2002-03-15 2005-07-20 西巴特殊化学品控股有限公司 4－氨基嘧啶及其在表面抗菌处理中的应用
DE10304870A1 (de) * 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
EP1846411A4 (en) * 2005-01-25 2010-08-04 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
EP2520567A3 (en) * 2006-02-23 2012-12-12 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
WO2007120528A2 (en) * 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
EP1882688A1 (en) 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
JP4840440B2 (ja) * 2008-12-24 2011-12-21 ソニー株式会社 画像処理装置およびその方法、並びにプログラム
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
NZ601547A (en) * 2010-01-25 2014-04-30 Chdi Foundation Inc Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2012003418A2 (en) * 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine d2 receptors
BR112013011737A2 (pt) 2010-11-15 2016-08-09 Univ Leuven Kath composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
ES2765805T3 (es) 2011-08-30 2020-06-11 Chdi Foundation Inc Inhibidores de kinurenina-3-monoxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CN103827095A (zh) 2011-08-30 2014-05-28 Chdi基金会股份有限公司 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法
CN110105340B (zh) 2013-12-24 2022-10-25 昂康塔睿迪斯股份有限公司 苯甲酰胺和烟酰胺化合物及其使用方法
BR112017000922A2 (pt) 2014-07-17 2018-01-16 Chdi Foundation, Inc. métodos e composições para tratar distúrbios relacionados ao hiv

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE628766A (es) 1962-12-26
BE792206A (es) 1971-12-02 1973-06-01 Byk Gulden Lomberg Chem Fab
US5139998A (en) 1988-08-31 1992-08-18 Superconductor Technologies, Inc. Controlled thallous oxide evaporation for thallium superconductor films and reactor design
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
FR2663638B2 (fr) 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
JP2518965B2 (ja) 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
FR2668771B1 (fr) 1990-11-06 1995-03-17 Inst Nat Sante Rech Med Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
DE4425145A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
FR2742149B1 (fr) 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
CN1146551C (zh) 2004-04-21
AU717726B2 (en) 2000-03-30
US6352981B1 (en) 2002-03-05
JP2000505072A (ja) 2000-04-25
US6214822B1 (en) 2001-04-10
EP0877744B1 (de) 2004-08-11
TR199801302T2 (xx) 1998-11-23
ATE273301T1 (de) 2004-08-15
CN1075070C (zh) 2001-11-21
DE19600934A1 (de) 1997-07-17
KR19990077127A (ko) 1999-10-25
CN1212692A (zh) 1999-03-31
CA2241787C (en) 2006-04-04
HUP9901590A3 (en) 2002-01-28
HU228457B1 (en) 2013-03-28
TW475929B (en) 2002-02-11
BG102616A (en) 1999-04-30
SK94198A3 (en) 1999-03-12
PL327692A1 (en) 1998-12-21
CZ297981B6 (cs) 2007-05-16
WO1997025324A1 (de) 1997-07-17
DE59711847D1 (de) 2004-09-16
CZ215998A3 (cs) 1999-05-12
HUP9901590A2 (hu) 1999-08-30
IL125076A0 (en) 1999-01-26
CN1348956A (zh) 2002-05-15
AR005868A1 (es) 1999-07-21
NO983187L (no) 1998-09-09
NO316753B1 (no) 2004-04-26
ZA97209B (en) 1998-07-10
SK284987B6 (sk) 2006-04-06
CO4790173A1 (es) 1999-05-31
EP0877744A1 (de) 1998-11-18
KR100441073B1 (ko) 2004-11-16
ES2225947T3 (es) 2005-03-16
BG64098B1 (bg) 2003-12-31
AU1440797A (en) 1997-08-01
CA2241787A1 (en) 1997-07-17
IL125076A (en) 2001-05-20
HRP970021A2 (en) 1998-04-30
JP4349657B2 (ja) 2009-10-21
NZ326332A (en) 1999-04-29

Similar Documents

Publication Publication Date Title
MX9805499A (es) Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.
MX9700430A (es) El uso de compuestos heterociclicos.
BG101110A (en) Substituted pyrimidine compounds and their application
MX9700557A (es) Dihidrobenzofuranos.
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
ES2179490T3 (es) Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5.
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
MX9703430A (es) Uso de dioxomorfolinas para la lucha contra endoparasitos, nuevas dioxomorfolinas y procedimiento para su produccion.
HK1046403A1 (en) Nematicidal trifluorobutenes.
MY120511A (en) New pesticides
MXPA02012203A (es) Analogos de peptido 1 tipo glucagon.
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
MX9603465A (es) N-pirazolilanilinas y n-pirazolilaminopiridinas como agentes pesticidas.
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
BG101113A (en) Triazole compounds and their application
YU2500A (sh) Alatrofloksacin parenteralni preparati
ID27440A (id) Proses untuk menyiapkan penengah-penengah
PE20399A1 (es) Muteina ob
ZA983231B (en) Substituted benzyloxyimino compounds.
PL313594A1 (en) Triaryl ethylene derivatives for therapeutic applications
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.